Page 29 - Tata_Chemicals_yearly-reports-2017-18
P. 29

Mithapur expansion to




                  meet pharmaceutical




                  bicarb demand






                  New plant will meet export standards                                                                       Integrated Report
                  for US and European markets





                  Tata Chemicals' sodium bicarbonate   Currently, demand in India for pharma
                  capacity at Mithapur will increase by   grade sodium bicarbonate is being met   Looking ahead
                  almost one third, when a new world-  largely by reprocessing and repackaging
                  class pharmaceutical grade plant comes   of industrial grade and food grade   •   Swiftly establish market presence
                  onstream in late 2019. It is part of our   products. Customers in the country’s   •   Enjoy  rst-mover advantage
                  strategy to maintain volume market share   rapidly growing pharmaceutical industry   •   Convert parts of the existing sodium
                  in India and increase value-added branded   are demanding high quality products   bicarbonate to pharma grade   Statutory Reports
                  share in a market driven by strong   from certi ed facilities. Regulations are   through an identi ed contract
                  macroeconomic and demographic trends.  also likely to tighten and come closer to   manufacturer under TCL’s direct
                                                     the standards that exist in the European   supervision duly validated by the
                  The new capacity will support our   and US markets. Products meeting these   Innovation Centre and the Mithapur
                  recently launched Medikarb product, a   stringent standards will  nd additional   technical services team.
                  pharma grade sodium bicarbonate that   opportunities in the export markets.
                  is subject to regulations with state Food
                  & Drug Administration and Central Drug   The new plant with a proposed expansion
                  Standard Control Organization. Of all   of bicarb capacity of 28,000 MTPA will
                  the applications of sodium bicarbonate,   use recovered carbon dioxide from
                  pharma applications in excipients,   existing carbonating tower vents. This
                  formulations, and haemodialysis    carbon dioxide recovery will be another
                  concentrates require the highest purity   pioneering step towards sustainability
                  and hence command the highest      driven growth.                                                          Financial Statements
                  realisations.
                                                     To achieve this ‘value from waste’ strategy
                  We currently produce more than 100,000   and reduce our carbon footprint scientists
                  MTPA across four categories technical,   from the Innovation Centre in Pune are
                            re ned, Alkakarb (animal   working closely with the manufacturing
                               feed) and Sodakarb    team from Mithapur, and colleagues in
                                 (food grade).       Cheshire for carbon dioxide recovery in
                                                     their respective plants. An investment of
                                                     ` 100 crore is expected for this.







                                                                                            Basic chemicals - Case study  27
   24   25   26   27   28   29   30   31   32   33   34